Inventiva (IVEVF) Non-Current Debt (2018 - 2025)
Inventiva (IVEVF) posted Non-Current Debt of $32.1 million for Q4 2025, down 45.09% on a QoQ basis from $58.4 million in Q2 2025, and down 38.07% year-over-year from $51.8 million in Q4 2024.
Analysis
Inventiva (IVEVF) Non-Current Debt (2018 - 2025) Analysis & Trends
Inventiva has reported Non-Current Debt for 8 years, with the latest figure at $32.1 million in Q4 2025.
- On a quarterly basis, Non-Current Debt fell 38.07% year-over-year to $32.1 million in Q4 2025; TTM through Dec 2025 was $32.1 million, a 38.07% decrease from a year earlier, with the FY2025 full-year figure at $32.1 million, down 38.07% from the prior year.
- Non-Current Debt was $32.1 million for Q4 2025 at Inventiva, down from $58.4 million in the prior quarter.
- The five-year high for Non-Current Debt was $58.4 million in Q2 2025, with the low at $10.1 million in Q4 2021.
- Average Non-Current Debt over 5 years is $30.8 million, with a median of $32.1 million recorded in 2025.
- The sharpest annual moves came in 2022 and 2025: Non-Current Debt soared 189.27% in 2022, then tumbled 38.07% in 2025.
- Over 5 years, Non-Current Debt stood at $10.1 million in 2021, then jumped by 189.27% to $29.2 million in 2022, then climbed by 18.4% to $34.6 million in 2023, then surged by 49.56% to $51.8 million in 2024, then sank by 38.07% to $32.1 million in 2025.
- The last three Non-Current Debt figures came in at $32.1 million (Q4 2025), $58.4 million (Q2 2025), and $51.8 million (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.04 Bn | 624.28 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 440.25 Bn | 433.68 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 365.65 Bn | 358.51 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 266.64 Bn | 258.95 Bn | 11.24 Bn | - |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | 60.50 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 17.02 Bn |
| 7 | Revolution Medicines | 44.19 Bn | 44.19 Bn | - | - |
| 8 | Incyte | 25.29 Bn | 20.75 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | - |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - | 32.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 32.07 Mn |
| Jun 30, 2025 | 58.41 Mn |
| Dec 31, 2024 | 51.78 Mn |
| Jun 30, 2024 | 50.45 Mn |
| Dec 31, 2023 | 34.62 Mn |
| Jun 30, 2023 | 33.77 Mn |
| Dec 31, 2022 | 29.24 Mn |
| Jun 30, 2022 | 14.34 Mn |
| Dec 31, 2021 | 10.11 Mn |
| Jun 30, 2021 | 12.14 Mn |
| Mar 31, 2021 | 12.15 Mn |
| Dec 31, 2020 | 11.97 Mn |
| Dec 31, 2019 | 2,213.78 |
| Dec 31, 2018 | 84,463.34 |